The deltoid muscle is often used for smaller injection volumes
Without add-back therapy, these medications can be associated with a decrease in bone density if taken longer than months
EMA Decision P/0336/2024 Paediatric Investigation Plan for retatrutide
It is possible to inject subcutaneously into the fatty tissue of the abdomen, thigh, or upper arm
Common side effects are typically mild and transient: Pain, redness, or swelling at the injection site (most frequent) Mild diarrhoea or gastrointestinal upset Headache or dizziness shortly after administration Itching or mild skin reactions Temporary pink/red discolouration of urine These effects usually resolve within 2448 hours without intervention
Aseptic technique, when combined with safe, sterile equipment, is essential for patient safety